Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
Scientific Reports
|
September 27, 2022
Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-up
Kuan-Yin Lin, Chia-Jui Yang, Hsin-Yun Sun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 4, 2020
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
Yu-Shan Huang, Chien-Yu Cheng, Bo-Huang Liou, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
March 7, 2021
Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan
Yi-Chun Lin, Yu-Lin Lee, Chien-Yu Cheng, et al.
Microbiology Spectrum
|
March 29, 2023
Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients
Yu-Shan Huang, Chien-Yu Cheng, Hsin-Yun Sun, et al.
Plos Neglected Tropical Diseases
|
June 13, 2020
Ongoing transmission of Entamoeba histolytica among newly diagnosed people living with HIV in Taiwan, 2009-2018
Sung-Hsi Huang, Mao-Song Tsai, Chun-Yuan Lee, et al.
Plos One
|
July 1, 2017
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
Kuan-Yin Lin, Chien-Yu Cheng, Chia-Wen Li, et al.
International Journal of Antimicrobial Agents
|
July 4, 2012
Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010
Cheng-Mao Ho, Mao-Wang Ho, Yung-Ching Liu, et al.
International Journal of Antimicrobial Agents
|
July 4, 2012
In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
Yuag-Meng Liu, Yao-Shen Chen, Han-Siong Toh, et al.
International Journal of Antimicrobial Agents
|
July 4, 2012
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
Po-Liang Lu, Yung-Ching Liu, Han-Siong Toh, et al.
International Journal of Antimicrobial Agents
|
July 4, 2012
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010
Chi-Chang Huang, Yao-Shen Chen, Han-Siong Toh, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
Scientific Reports
|
September 27, 2022
Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-up
Kuan-Yin Lin, Chia-Jui Yang, Hsin-Yun Sun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 4, 2020
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
Yu-Shan Huang, Chien-Yu Cheng, Bo-Huang Liou, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
March 7, 2021
Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan
Yi-Chun Lin, Yu-Lin Lee, Chien-Yu Cheng, et al.
Microbiology Spectrum
|
March 29, 2023
Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients
Yu-Shan Huang, Chien-Yu Cheng, Hsin-Yun Sun, et al.
Plos Neglected Tropical Diseases
|
June 13, 2020
Ongoing transmission of Entamoeba histolytica among newly diagnosed people living with HIV in Taiwan, 2009-2018
Sung-Hsi Huang, Mao-Song Tsai, Chun-Yuan Lee, et al.
Plos One
|
July 1, 2017
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
Kuan-Yin Lin, Chien-Yu Cheng, Chia-Wen Li, et al.
International Journal of Antimicrobial Agents
|
July 4, 2012
Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010
Cheng-Mao Ho, Mao-Wang Ho, Yung-Ching Liu, et al.
International Journal of Antimicrobial Agents
|
July 4, 2012
In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
Yuag-Meng Liu, Yao-Shen Chen, Han-Siong Toh, et al.
International Journal of Antimicrobial Agents
|
July 4, 2012
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
Po-Liang Lu, Yung-Ching Liu, Han-Siong Toh, et al.
International Journal of Antimicrobial Agents
|
July 4, 2012
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010
Chi-Chang Huang, Yao-Shen Chen, Han-Siong Toh, et al.
Page
of 8